Forschungsdatenbank PMU-SQQUID

Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations.
Jungbauer, C; Weseslindtner, L; Weidner, L; Gänsdorfer, S; Farcet, MR; Gschaider-Reichhart, E; Kreil, TR;
Transfusion. 2021; 61(1): 12-16.
Originalarbeiten (Zeitschrift)

Abstract/Keywords Web of Science PubMed PUBMED Central Full Text

PMU-Autor/inn/en

Jungbauer Christof

Abstract

Transfusion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent plasma is a promising treatment for severe coronavirus disease 2019 (COVID-19) cases, with success of the intervention based on neutralizing antibody content. Measurement by serologic correlates without biocontainment needs as well as an understanding of donor characteristics that may allow for targeting of more potent donors would greatly facilitate effective collection.

Useful keywords (using NLM MeSH Indexing)

Blood Donors

COVID-19/immunology

COVID-19/therapy*

COVID-19/virology*

Enzyme-Linked Immunosorbent Assay

Humans

Immunization, Passive/methods

SARS-CoV-2/immunology

SARS-CoV-2/pathogenicity*

Find related publications in this database (Keywords)

convalescent donor selection
COVID-19
ELISA correlation
severe acute respiratory syndromecoronavirus 2
virus neutralization